Nitrates, Nitrites, and Nitrosatable Drugs and Risk of Selected Birth Defects

硝酸盐、亚硝酸盐和亚硝化药物与特定出生缺陷的风险

• 批准号: 7243600
• 负责人: JEAN Diane BRENDER
• 金额: $ 37.38万
• 依托单位: TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-27 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7243600
• 关键词: Accounting; Address; Adrenergic beta-Antagonists; Age; Age-Years; Amides; Amines; Animal Model; Antibiotics; Antihistamines; Ascorbic Acid; Bacteria; Case-Control Studies; Cessation of life; Chemical Structure; Child; Cleft Palate; Communities; Condition; Congenital Abnormality; Congenital Heart Defects; Congenital neurologic anomalies; Coughing; Defect; Diet; Drug Exposure; Epidemiologic Studies; Exposure to; First Pregnancy Trimester; Food; Frequencies; Health; Hypersensitivity; Infant; Infant Mortality; Ingestion; Intake; Integration Host Factors; Interview; Iowa; Joints; Length of Stay; Limb structure; Link; Literature; Medicine; Modeling; Morbidity - disease rate; Neural Tube Defects; Neuraxis; Nitrates; Nitrites; Nitrosamines; Nitrosation; Nitroso Compounds; Occupational Exposure; Oral cavity; Participant; Pharmaceutical Preparations; Population; Population Study; Pregnancy; Pregnant Women; Preparation; Prevention; Publishing; Questionnaires; Reporting; Risk; Saliva; Sampling; Sleep; Source; Stomach; System; Texas; United States National Center for Health Statistics; Water; Woman; base; case control; cigarette smoking; design; dietary nitrate; drinking water; exposed human population; in vivo; inhibitor/antagonist; malformation; mortality; nitrate; oral cleft; prenatal; prenatal exposure

DESCRIPTION (provided by applicant): Congenital defects remain the greatest contributor to infant mortality; yet, the causes for the majority of these defects are either unknown or poorly understood. Amine- and amide-containing (nitrosatable) drugs and other compounds react with nitrite in the stomach to form N-nitroso compounds. In animal models, N-nitroso compounds have been found to induce a variety of congenital malformations. The few epidemiologic studies conducted in the past have focused on the separate effects of nitrates, nitrites, and nitrosatable drugs on risk of congenital malformations without consideration of their interaction in the endogenous formation of N- nitroso compounds. This case-control study will examine the separate and joint effects of prenatal exposures to nitrates, nitrites, and nitrosatable drugs on risk of selected congenital malformations (neural tube defects, limb malformations, oral clefts, and heart defects). Cases and controls will be obtained from the National Birth Defects Prevention Study (NBDPS), a multi-center study that covers populations in 10 different states. Subjects' usual intake of dietary nitrates, nitrites, and nitrosamines will be calculated from the NBDPS food frequency questionnaire. From the NBDPS interview, medications reported taken one month preconception and during the first trimester will be classified as to their likelihood of nitrosatability based on the literature and chemical structure. The periconceptional addresses of Iowa and Texas participants will be linked to community water systems and pertinent water nitrate sampling results. For Texas participants on private wells, we will model and predict nitrate levels with a multi-dimensional flow and transport model. We will analyze the separate and joint effects of nitrosatable precursors on risk of the selected malformations. We will also examine the effects of vitamins C and E (inhibitors of nitrosation) on the relations between nitrate/nitrite intake and nitrosatable drugs and risk of selected congenital malformations. Use of over-the- counter medications is fairly common during pregnancy according to a recently published study. Several over-the-counter preparations contain nitrosatable compounds as active ingredients. The proposed study will help us understand whether pregnant women who take these types of drugs and also consume greater amounts of nitrates and nitrites are at increased risk of having offspring with birth defects. The study is also designed to examine whether higher intakes of vitamin C or E decrease these potential risks.

描述（由申请人提供）：先天性缺陷仍然是婴儿死亡的最大原因；然而，大多数这些缺陷的原因要么是未知的，要么是知之甚少的。含胺和酰胺（可亚硝基）的药物和其他化合物与胃中的亚硝酸盐反应形成n -亚硝基化合物。在动物模型中，已发现n -亚硝基化合物可诱导多种先天性畸形。过去进行的少数流行病学研究侧重于硝酸盐、亚硝酸盐和亚硝基药物对先天性畸形风险的单独影响，而没有考虑它们在内源性N-亚硝基化合物形成中的相互作用。本病例对照研究将检查产前暴露于硝酸盐、亚硝酸盐和亚硝基药物对选定的先天性畸形（神经管缺陷、肢体畸形、唇裂和心脏缺陷）风险的单独和联合影响。病例和对照将从国家出生缺陷预防研究（NBDPS）中获得，这是一项涵盖10个不同州人口的多中心研究。受试者通常的膳食硝酸盐、亚硝酸盐和亚硝胺摄入量将从NBDPS食物频率问卷中计算出来。根据NBDPS的访谈，孕前一个月和妊娠早期服用的药物将根据文献和化学结构对其硝基性的可能性进行分类。爱荷华州和德克萨斯州参与者的感知地址将与社区供水系统和相关的水硝酸盐采样结果联系起来。对于德克萨斯州的私人井参与者，我们将用多维流动和运输模型建模和预测硝酸盐水平。我们将分析可硝化前体对所选畸形风险的单独和联合影响。我们还将研究维生素C和E（亚硝化抑制剂）对硝酸盐/亚硝酸盐摄入量与亚硝化药物和选定的先天性畸形风险之间的关系的影响。根据最近发表的一项研究，在怀孕期间使用非处方药物相当普遍。一些非处方制剂含有亚硝基化合物作为活性成分。这项拟议的研究将帮助我们了解孕妇服用这些类型的药物并摄入大量的硝酸盐和亚硝酸盐是否会增加其后代有出生缺陷的风险。该研究还旨在调查摄入更多的维生素C或E是否会降低这些潜在的风险。